Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Research output
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
A Multicentre, Double-Blind, Randomized, Placebo Controlled, Parallel group, Phase 3 Safety Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents with Severe Uncontrolled Asthma (DESTINATION)
Gillman, Andrew
(Primary Chief Investigator (PCI))
Hazard, Anita
(Project Manager)
Medicine Alfred Hospital
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
2/12/19
→
1/05/22
View all
View less
Keywords
Respiratory medicine
Asthma
Clinical trial